Department of Oral and Maxillofacial Surgery, Kanazawa University Graduate School of Medical Science, 13-1 Takaramachi, Kanazawa, Ishikawa 920-8641, Japan.
Oncol Rep. 2011 Dec;26(6):1555-60. doi: 10.3892/or.2011.1419. Epub 2011 Aug 10.
It is well documented that the binding of urokinase-type plasminogen activator (uPA) to its receptor (uPAR), which has been implicated in cancer invasion and metastasis, is regulated by several inhibitors such as maspin. In this study, we investigated the interrelationship between clinicopathologic findings and expression of uPA, uPAR and maspin in oral squamous cell carcinoma (OSCC) to elucidate the participation of maspin in the uPA/uPAR system in the malignant behavior of OSCC. Using immunohistochemical techniques to examine the expression levels of uPA, uPAR and maspin in 54 cases of OSCC, we also compared the clinicopathologic features of OSCC with the expression levels of each. Moreover, we examined the expression of uPA, uPAR and maspin in six cell lines derived from OSCC using reverse transcriptase-polymerase chain reaction (RT-PCR) and Western blotting. uPA and uPAR showed a positive correlation with the mode of cancer invasion; conversely maspin showed a negative correlation with the mode of invasion. Multivariate analysis revealed that only two factors (N-category and uPA+/uPAR+/maspin- expression pattern) were significant and independent variables with relative risks of 3.84 and 2.52, respectively. In particular, tumors exhibiting an expression pattern of uPA+/uPAR+/maspin- were highly malignant and were associated with the worst survival rate (5-year overall survival rate, 29.4%), while tumors with an expression pattern, uPA-/uPAR-/Μaspin+, showed the most favorable survival rate (5-year overall survival rate, 77.8%). In vitro, lower expression of maspin was also noted in the cell lines derived from grade 4D OSCC, which exhibited a stronger invasive potential than the cells lines derived from the other grades of OSCC, while uPA and uPAR demonstrated an expression trend opposite to maspin. These results indicate that uPA, uPAR and maspin expression patterns may be useful markers for evaluating the clinical course or prognosis of OSCC patients.
已有大量文献记载尿激酶型纤溶酶原激活物(uPA)与其受体(uPAR)的结合,这与癌症的侵袭和转移有关,而这种结合受许多抑制剂的调节,如 maspin。在这项研究中,我们研究了口腔鳞状细胞癌(OSCC)中临床病理发现与 uPA、uPAR 和 maspin 表达之间的相互关系,以阐明 maspin 在 OSCC 恶性行为中的 uPA/uPAR 系统中的参与作用。我们使用免疫组织化学技术检测了 54 例 OSCC 中 uPA、uPAR 和 maspin 的表达水平,并将 OSCC 的临床病理特征与每种表达水平进行了比较。此外,我们使用逆转录-聚合酶链反应(RT-PCR)和 Western blotting 检测了 6 种源自 OSCC 的细胞系中 uPA、uPAR 和 maspin 的表达。uPA 和 uPAR 与癌症侵袭方式呈正相关;相反,mpsin 与侵袭方式呈负相关。多变量分析显示,只有两个因素(N 分类和 uPA+/uPAR+/mpsin-表达模式)是显著和独立的变量,其相对风险分别为 3.84 和 2.52。特别是,表现出 uPA+/uPAR+/mpsin-表达模式的肿瘤具有高度恶性,与最差的生存率(5 年总生存率为 29.4%)相关,而表现出 uPA-/uPAR-/mpsin+表达模式的肿瘤具有最有利的生存率(5 年总生存率为 77.8%)。在体外,我们还注意到源自 4D 级 OSCC 的细胞系中 maspin 的表达较低,其侵袭潜力强于源自其他等级 OSCC 的细胞系,而 uPA 和 uPAR 的表达趋势与 maspin 相反。这些结果表明,uPA、uPAR 和 maspin 的表达模式可能是评估 OSCC 患者临床过程或预后的有用标志物。